There were 49 DCIS in 325 breast cancers, and nine cases out of sixty‐two BRCA mutation were DCIS, 2% (n = 1) carried a BRCA1 mutation, and 16.4% (n = 8) carried a BRCA2 mutation (Table 1). This evidence concerns the gene BRCA2 and ductal breast carcinoma in situ.